The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutationsResearch in context

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutationsResearch in context

Summary: Background: Currently, the role of EGFR-TKIs as adjuvant therapy for stage I, especially IA NSCLC, after surgical resection remains unclear. We aimed to compare the effect of adjuvant EGFR-TKIs with observation in such patients by incorporating an established 14-gene molecular assay for ri...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Yu Jiang, Yuechun Lin, Wenhai Fu, Qihua He, Hengrui Liang, Ran Zhong, Ran Cheng, Bingliang Li, Yaokai Wen, Huiting Wang, Jianfu Li, Caichen Li, Shan Xiong, Songan Chen, Jianxing Xiang, Michael J. Mann, Jianxing He, Wenhua Liang
Format: Artykuł
Język:English
Wydane: Elsevier 2023-10-01
Seria:EClinicalMedicine
Hasła przedmiotowe:
Adjuvant therapy
EGFR-TKI
Non–small-cell lung cancer
Stage I
Risk stratification
Dostęp online:http://www.sciencedirect.com/science/article/pii/S2589537023003826

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023003826

Podobne zapisy